drug
as of 2026-07-01NBI-1117570
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Neurocrine Biosciences
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
NCT07288333Phase 2Recruiting
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here